GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment, but maintaining weight loss after the medications stop remains a...

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever...

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...

Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF) and in collaboration...

MONDAY, Jan. 12, 2026 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC)...

MONDAY, Jan. 12, 2026 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC)...

Glucagon-like peptide-1 (GLP-1) receptor agonist drugs, like the popular weight-loss jabs Wegovy and Ozempic, have proven to be immensely effective....

Glucagon-like peptide-1 (GLP-1) receptor agonist drugs, like the popular weight-loss jabs Wegovy and Ozempic, have proven to be immensely effective....

Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.